EXHIBIT 32.1
Published on March 31, 2006
EXHIBIT
32.1
CERTIFICATION
OF
CHIEF
EXECUTIVE OFFICER
PURSUANT
TO
18
U.S.C.
SECTION 1350
I,
Chang
H. Ahn, Chief Executive Officer of Rexahn Pharmaceuticals, Inc. (the "Company"),
certify, pursuant to 18 U.S.C. Section 1350, as adopted by Section 906 of the
Sarbanes-Oxley Act of 2002, that:
|
(1)
|
the
Annual Report on Form 10-KSB of the Company for the fiscal year ended
December 31, 2005 as filed on the date hereof with the Securities and
Exchange Commission (the "Report") fully complies with the requirements
of
Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as
amended;
and
|
|
(2)
|
the
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company.
|
|
Date:
March 31, 2006
|
|
|
/s/
Chang H. Ahn
|
|
|
Chang
H. Ahn
|
|
|
Chief
Executive Officer
|
|
The
foregoing certification is being furnished solely pursuant to 18 U.S.C. Section
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
and
is not being "filed" as part of the Form 10-KSB or as a separate disclosure
document for purposes of Section 18 of the Securities Exchange Act of 1934,
as
amended (the "Exchange Act"), or otherwise subject to liability under that
section. This certification shall not be deemed to be incorporated by reference
into any filing under the Securities Act of 1933, as amended, or the Exchange
Act except to the extent that this Exhibit 32.1 is expressly and specifically
incorporated by reference in any such filing.